dronabinol has been researched along with DDPAC in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casarejos, MJ; de Yebenes, JG; Fernandez Ruiz, J; Fernandez-Estevez, M; Gomez, A; Guzman, M; Mena, MA; Muñoz, MP; Perucho, J; Sagredo, O | 1 |
1 other study(ies) available for dronabinol and DDPAC
Article | Year |
---|---|
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
Topics: Amyloidosis; Animals; Behavior, Animal; Biogenic Monoamines; Cannabidiol; Disease Models, Animal; Dopamine; Dronabinol; Drug Combinations; Frontotemporal Dementia; Glutathione; Humans; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Phytotherapy; Plant Extracts; Synaptic Transmission; Tauopathies | 2013 |